Skip to main content
. 2013 May 14;108(11):2241–2249. doi: 10.1038/bjc.2013.202

Table 1. Percentage and relative risks for initiators affecting the transition rate from free-of-breast cancer to the pre-clinical screen-detectable phase (PCDP).

Variables Percentage (%) Relative risk of being breast cancer in the PCDP (pre-symptomatic cases) References
Gene mutation
BRCA1 gene mutation 0.11 20.26 Peto et al, 1999; Chen and Parmigiani, 2007
BRCA2 gene mutation
0.12
15.44
 
Breast density (BI-RADS)
Almost entirely fat 0.92 1.00 del Carmen et al, 2007; Cumming et al, 2009
Scattered fibroglandular densities 15.86 2.03  
Heterogeneously dense 56.09 2.95  
Extremely dense
27.13
4.03
 
Polygenes (dbSNP no.) per allele
rs2981582 38 1.26 Easton et al, 2007; Hunter et al, 2007
rs3803662 25 1.20 Easton et al, 2007
rs889312 28 1.13 Easton et al, 2007
rs3817198 30 1.07 Easton et al, 2007
rs13281615 40 1.08 Stacey et al, 2007
rs13387042 50 1.20 Cox et al, 2007
rs1045485
86
1.13
Easton et al, 2007
BMI (kg m−2)
⩽23 37.11 1.00 Chen et al, 2004
>23
62.89
2.59
Hsieh et al, 2002
Age at first full-term pregnancy (years)
⩽25 66.53 1.00 Chen et al, 2004
>25 33.47 1.99 Hsieh et al, 2002